BioSpace News Archive

TaiGen Biotechnology Company, Limited announced that they have signed an exclusive licensing agreement with Luminarie Canada Inc., a leading Canadian pharmaceutical company, to develop and commercialize Taigexyn® in Canada, Australia and New Zealand.

BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell therapies for neurodegenerative diseases, announced the presentation of a poster titled, “Advancing NurOwn® for ALS: Phase 3 Clinical Trial Design” at the Annual Northeast ALS Meeting, being held virtually.

C-RAD announced that multiple sites in the state of New South Wales, Australia decided to implement C-RAD’s Catalyst+ HD™ and Sentinel 4DCT™ solution.

Iterum Therapeutics plc announced that, based on discussions at a pre-NDA meeting with the U.S. Food and Drug Administration, it plans to proceed with an NDA submission for sulopenem etzadroxil/probenecid, a bilayer tablet, for the treatment of uncomplicated urinary tract infections in patients with a quinolone-resistant pathogen.

Lead program FL-101, an IL-1β neutralizing antibody, expected to enter clinical testing in 1H-2021 in patients with non-small cell lung cancer Kris Jenner, Managing Member at Rock Springs Capital, to join Flame’s Board of Directors [30-September-2020] NEW YORK , Sept. 30, 2020 /PRNewswire/ -- Flame Biosciences, a clinical-stage biopharmaceutical company focu

Fluxion Biosciences, the global leader in automated patch clamp systems for ion channel drug discovery, just announced the launch of IonFlux Mercury Ultra, the system delivering the highest levels of throughput and modularity ever offered in a patch clamp platform.

PerkinElmer, Inc. , a global leader committed to innovating for a healthier world, today announced that the Company’s EONIS™ screening assay for newborns that simultaneously tests for SMA (spinal muscular atrophy), SCID (severe combined immunodeficiency) and XLA (X-linked agammaglobulinemia) has receiv

NeuroOne Medical Technologies Corporation (OTCQB: NMTC; NeuroOne), a medical technology company focused on improving surgical care options and outcomes for patients suffering from brain and spine-related neurological disorders, today announces the release of its white pape

Ovation Science Inc. is pleased to announce it will be participating in the Gravitas Healthcare Investor Day taking place Thursday, October 1st, 2020 virtually.

StopAfib.org’s annual “Get in Rhythm. Stay in Rhythm. ® Atrial Fibrillation Patient Conference” is for those living with atrial fibrillation (the most common irregular heartbeat, which increases stroke risk by 500%). For the first time ever, the conference is virtual, which means anyone anywhere in the world has the good fortune